Your browser doesn't support javascript.
loading
Association of a single nucleotide polymorphism upstream of ICOS with Japanese autoimmune hepatitis type 1.
Higuchi, Takashi; Oka, Shomi; Furukawa, Hiroshi; Nakamura, Minoru; Komori, Atsumasa; Abiru, Seigo; Nagaoka, Shinya; Hashimoto, Satoru; Naganuma, Atsushi; Naeshiro, Noriaki; Yoshizawa, Kaname; Shimada, Masaaki; Nishimura, Hideo; Tomizawa, Minoru; Kikuchi, Masahiro; Makita, Fujio; Yamashita, Haruhiro; Ario, Keisuke; Yatsuhashi, Hiroshi; Tohma, Shigeto; Kawasaki, Aya; Ohira, Hiromasa; Tsuchiya, Naoyuki; Migita, Kiyoshi.
Afiliação
  • Higuchi T; Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Oka S; Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Furukawa H; Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Nakamura M; Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Komori A; Clinical Research Center, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Abiru S; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Nagaoka S; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Hashimoto S; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Naganuma A; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Naeshiro N; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Yoshizawa K; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Shimada M; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Nishimura H; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Tomizawa M; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Kikuchi M; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Makita F; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Yamashita H; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Ario K; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Yatsuhashi H; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Tohma S; Clinical Research Center, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Kawasaki A; NHO-AIH study group, National Hospital Organization Nagasaki Medical Center, Omura, Japan.
  • Ohira H; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Tsuchiya N; Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Migita K; Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
J Hum Genet ; 62(4): 481-484, 2017 Apr.
Article em En | MEDLINE | ID: mdl-27974812
ABSTRACT
Autoimmune hepatitis (AIH) is an uncommon chronic autoimmune liver disease. Several studies reported the association of polymorphisms between CD28, CTLA4 and ICOS gene cluster in 2q33.2 with autoimmune or inflammatory diseases. The previous genome-wide association study on type 1 AIH in a European population has reported a risk G allele of a single nucleotide polymorphism (SNP), rs4325730, in this region. Here, we conducted an association study of this SNP with type 1 AIH in a Japanese population, as a replication study.An association study of rs4325730 was conducted in 343 Japanese AIH patients and 315 controls.We found that rs4325730 is associated with AIH (P=0.0173, odds ratio (OR) 1.30, 95% confidence interval (CI) 1.05-1.62, under the allele model for G allele, P=0.0070, OR 1.62, 95% CI 1.14-2.31, under the dominant model for G allele). This SNP was strongly associated with definite AIH (P=0.0134, OR 1.36, 95% CI 1.07-1.74; under allele model for G, P=0.0035, OR 1.85, 95% CI 1.22-2.81, under dominant model for G).This is the first replication association study of rs4325730 upstream of ICOS with AIH in the Japanese population and rs4325730G is a risk allele.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite Autoimune / Predisposição Genética para Doença / Proteína Coestimuladora de Linfócitos T Induzíveis Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite Autoimune / Predisposição Genética para Doença / Proteína Coestimuladora de Linfócitos T Induzíveis Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão